<?xml version="1.0" encoding="UTF-8"?>
<p id="Par89" class="p">Since parasitic protozoa are very sensitive to oxidative stress [
 <xref ref-type="bibr" rid="CR39" class="xref">39</xref>], the most common trypanocidal and anti-chagasic drugs like Nitroimidazoles derived (BNZ) and Nitrofurans (NFX) were developed based on their capability to induce Reactive Oxygen Species (ROS) production [
 <xref ref-type="bibr" rid="CR40" class="xref">40</xref>]. However, the clinical use of both medicines has been limited due to their high toxicity [
 <xref ref-type="bibr" rid="CR41" class="xref">41</xref>], mutagenic potential [
 <xref ref-type="bibr" rid="CR42" class="xref">42</xref>], the severity of their side effects [
 <xref ref-type="bibr" rid="CR38" class="xref">38</xref>, 
 <xref ref-type="bibr" rid="CR41" class="xref">41</xref>], and the lack of significant effects on clinical disease progression in the late stages of 
 <italic class="italic">T. cruzi</italic> infection [
 <xref ref-type="bibr" rid="CR8" class="xref">8</xref>, 
 <xref ref-type="bibr" rid="CR37" class="xref">37</xref>].
</p>
